Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

被引:4
|
作者
Huang, Chung-Feng [1 ,2 ]
Huang, Ching-I [1 ,3 ]
Yeh, Ming-Lun [3 ]
Huang, Jee-Fu [3 ,4 ]
Hsieh, Ming-Yen [3 ]
Lin, Zu-Yau [3 ,4 ]
Chen, Shinn-Cherng [3 ,4 ]
Yu, Ming-Lung [3 ,4 ]
Dai, Chia-Yen [3 ,4 ,5 ,6 ]
Chuang, Wan-Long [3 ,4 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan
来源
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES | 2015年 / 31卷 / 05期
关键词
Genotype; Hepatitis C virus; Interleukin-28B; Mixed infection; INTERLEUKIN-28B GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; VIRAL-HEPATITIS; HCV; INTERFERON; IL28B; SUPERINFECTION; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.kjms.2015.02.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The prevalence and characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection (HCV-1/ 2) remains unclear. For each HCV-1/ 2 patient with histological data available, two age-and sex-matched HCV-1 and HCV-2 infected patients were selected for comparison, respectively. Of the 2776 patients, 261 (9.4%) patients were identified as having mixed HCV-1/ 2 infection. The histological severity did not differ among HCV-1/ 2 patients and controls. The proportion of patients with the interleukin-28B (IL-28B) rs8099917 TT genotype did not differ between patients with mixed-1/ 2 and HCV-1 infection (82.6% vs. 86.5%, p = 0.38). However, HCV-2 infected patients had a significantly higher proportion of the rs8099917 TT genotype compared to patients with mixed HCV-1/ 2 infections (91.6% vs. 82.6%, p = 0.03). The HCV RNA levels were similar in patients with HCV-1/ 2 and HCV-1 infections (5.5 +/- 0.8 log IU/mL vs. 5.5 +/- 0.9 log IU/L, p = 0.73), which were both significantly higher than that of HCV-2 infection (5.1 +/- 0.9 log IU/mL, both p < 0.001). Linear regression analysis revealed that the factors of HCV-1/2 infection [beta: 0.204; 95% confidence interval (CI): 0.183-0.598, p < 0.001], bodyweight(beta:0.150;CI: 0.003-0.021, p = 0.008), and age (beta: - 0.139; CI: - 0.020 to - 0.002, p = 0.01) were independently correlated with HCV RNA levels in patients with HCV-2 and mixed HCV-1/2 infection. We concluded that the host genetic and viral presentations of patients with mixed HCV-1/2 infection were more similar to those of patients with HCV-1 infection than patients with HCV-2 infection. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [21] Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients
    Anggorowati, Nungki
    Yano, Yoshihiko
    Heriyanto, Didik Setyo
    Rinonce, Hanggoro Tri
    Utsumi, Takako
    Mulya, Deshinta Putri
    Subronto, Yanri Wijayanti
    Hayashi, Yoshitake
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (06) : 857 - 865
  • [22] Changes in Hepatitis C Virus Genotype Distribution in Chronic Hepatitis C Infection Patients
    Selek, Mehmet Burak
    Baylan, Orhan
    Karagoz, Ergenekon
    Ozyurt, Mustafa
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2018, 36 (03) : 416 - 421
  • [23] Mixed cryoglobulinemia in patients with hepatitis C virus infection
    Musset, L
    Lunel, F
    Cacoub, P
    Opolon, P
    PRESSE MEDICALE, 1996, 25 (12): : 595 - 598
  • [24] Virological characteristics of hepatitis B genotype G/A2 recombination virus in Japan
    Tsuzuki, Yuji
    Watanabe, Tsunamasa
    Iio, Etsuko
    Fujisaki, Seiichiro
    Ibe, Shiro
    Kani, Satomi
    Hamada-Tsutsumi, Susumu
    Yokomaku, Yoshiyuki
    Iwatani, Yasumasa
    Sugiura, Wataru
    Okuse, Chiaki
    Okumura, Akihiko
    Sato, Yoshihisa
    Tanaka, Yasuhito
    HEPATOLOGY RESEARCH, 2016, 46 (08) : 775 - 783
  • [25] Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure
    Dai, Chia-Yen
    Chuang, Wan-Long
    Huang, Jee-Fu
    Hsieh, Ming-Yen
    Yu, Ming-Lung
    HEPATOLOGY, 2008, 48 (02) : 692 - 693
  • [26] Therapy of Genotype-1 Hepatitis C Virus Infection for Patients With Renal Disease
    Lowe, Anson W.
    Moseley, Richard H.
    GASTROENTEROLOGY, 2016, 150 (07) : 1493 - 1494
  • [27] Update on the Treatment of Patients With Non-Genotype 1 Hepatitis C Virus Infection
    Mangia, Alessandra
    Mottola, Leonardo
    Piazzolla, Valeria
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1294 - 1300
  • [28] Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection
    D'Offizi, Gianpiero
    Camma, Calogero
    Taibi, Chiara
    Schlag, Michael
    Weber, Karin
    Palma, Maria
    De Masi, Ralph
    Janssen, Katrien
    Witek, James
    Lionetti, Raffaella
    NEW MICROBIOLOGICA, 2017, 40 (01): : 19 - 26
  • [29] Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Koichi Takaguchi
    Hidenori Toyoda
    Akemi Tsutsui
    Yoshiyuki Suzuki
    Makoto Nakamuta
    Michio Imamura
    Tomonori Senoh
    Takuya Nagano
    Toshifumi Tada
    Yoshihiko Tachi
    Atsushi Hiraoka
    Kojiro Michitaka
    Hiroshi Shibata
    Kouji Joko
    Hironao Okubo
    Kunihiko Tsuji
    Shintaro Takaki
    Tsunamasa Watanabe
    Chikara Ogawa
    Kazuaki Chayama
    Takashi Kumada
    Masatoshi Kudo
    Hiromitsu Kumada
    Journal of Gastroenterology, 2019, 54 : 742 - 751
  • [30] Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Takaguchi, Koichi
    Toyoda, Hidenori
    Tsutsui, Akemi
    Suzuki, Yoshiyuki
    Nakamuta, Makoto
    Imamura, Michio
    Senoh, Tomonori
    Nagano, Takuya
    Tada, Toshifumi
    Tachi, Yoshihiko
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Shibata, Hiroshi
    Joko, Kouji
    Okubo, Hironao
    Tsuji, Kunihiko
    Takaki, Shintaro
    Watanabe, Tsunamasa
    Ogawa, Chikara
    Chayama, Kazuaki
    Kumada, Takashi
    Kudo, Masatoshi
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (08) : 742 - 751